Retatrutide, from Soma Corp., is attracting considerable attention as a innovative therapy for weight management . This innovative drug integrates the properties of a GLP-1 receptor agonist read more and a GIP receptor activator , intended to effectively promote reduced body fat but also improve underlying metabolic conditions . Preliminary human t